[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351101-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351101-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","kif20a-inhibits-trim21-dependent-ubiquitination-of-dhx9-to-boost-sox2-stability-enhancing-oscc-stemness-and-ferroptosis-resistance","KIF20A inhibits TRIM21-dependent ubiquitination of DHX9 to boost SOX2 stability - enhancing OSCC stemness and ferroptosis resistance","","Oral squamous cell carcinoma (OSCC) shows poor outcomes driven by persistent cancer stem cells and ferroptosis resistance, yet the coupled molecular control is unclear. This study finds KIF20A significantly upregulated in OSCC and linked to worse clinical outcomes. KIF20A regulates DHX9 nucleocytoplasmic distribution and blocks TRIM21-mediated K48-linked ubiquitination at DHX9-K755, preventing degradation. Stabilized DHX9 increases SOX2 mRNA stability, elevating SOX2 to support stemness and ferroptosis evasion. KIF20A also activates PI3K/AKT signaling, while ENMD-2076 reduces KIF20A, attenuates stem-like traits, increases cisplatin sensitivity, and suppresses tumor growth.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/kif20a-inhibits-trim21-dependent-ubiquitination-of-dhx9-to-boost-sox2-stability-enhancing-oscc-stemness-and-ferroptosis-resistance/351101/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/kif20a-inhibits-trim21-dependent-ubiquitination-of-dhx9-to-boost-sox2-stability-enhancing-oscc-stemness-and-ferroptosis-resistance/351101.png","ImageObject",300,407,{"name":42,"@type":43},"Levi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does KIF20A play in OSCC progression and patient outcomes?","Question",{"text":63,"@type":64},"KIF20A is significantly overexpressed in OSCC and strongly correlates with adverse clinical outcomes. It promotes cancer stem cell-like phenotypes and contributes to ferroptosis resistance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does KIF20A influence DHX9 stability?",{"text":68,"@type":64},"KIF20A alters DHX9 nucleocytoplasmic distribution and inhibits TRIM21-mediated K48-linked polyubiquitination at DHX9-K755. This prevents proteasomal degradation and enhances DHX9 protein stability.",{"name":70,"@type":61,"acceptedAnswer":71},"How does DHX9 affect SOX2 and ferroptosis resistance?",{"text":72,"@type":64},"Elevated DHX9 increases SOX2 mRNA stability, leading to upregulation of SOX2. SOX2 then supports both cancer stem cell maintenance and resistance to ferroptosis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351101,1790167997,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nKIF20A inhibits TRIM21-dependent ubiquitination of DHX9 to boost SOX2 stability, enhancing OSCC stemness and ferroptosis resistance  \nZiyun Zhang 1,2,8, Yi Li1,2,8, Jingjiang Hu1, Xingjie Tang 1, Zhanpeng Li 1, Xiaoyan Sun1, Dade Feng1, Yixin Yao1, Chao Mao3, Yongguang Tao 4, Li Xie5, Huaiqing Luo1, Yufei Li1, Xing Yu1,2,6, Xiaoning Peng1, Li Cong 1,2 ✉ and Yiqun Jiang 1,2,7 ✉  \n© The Author(s) 2026  \n|  |  |  |\n| --- | --- | --- |\n|  | Oral squamous cell carcinoma (OSCC) is an aggressive malignancy characterized by poor prognosis, largely attributable to cancer stem cell (CSC) persistence and ferroptosis resistance. However, the molecular mechanisms that coordinately regulate stemness maintenance and ferroptosis suppression in OSCC remain insufﬁciently characterized. In this study, KIF20A was identiﬁed assigniﬁcantly overexpressed in OSCC and strongly correlated with adverse clinical outcomes. An integrative approach identiﬁed DHX9 as a candidate interactor of KIF20A. Mechanistic investigations revealed that KIF20A regulates DHX9 nucleocytoplasmic distribution and inhibits TRIM21-mediated K48-linked polyubiquitination at DHX9-K755, thereby preventing its proteasomal degradation and enhancing protein stability. Elevated DHX9 enhanced SOX2 mRNA stability, leading to upregulation of SOX2, a central regulator of both CSC maintenance and ferroptosis resistance. Functionally, KIF20A promoted CSC phenotypes, inhibited ferroptosis in vitro and in vivo, and activated the PI3K/AKT signaling pathway. Notably, treatment with ENMD-2076 (identiﬁed through Connectivity Map analysis) signiﬁcantly reduced KIF20A expression, attenuated CSC characteristics, augmented cisplatinsensitivity, and exerted marked antitumor activity. These ﬁndings elucidate a novel KIF20A-DHX9-SOX2 regulatory axis that simultaneously governs CSC maintenance and ferroptosis evasion in OSCC. Targeting KIF20A, either as a monotherapy or in |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| combination with chemotherapy, may offer a promising strategy to improve therapeutic outcomes in OSCC. |  |  |\n|  | Cell Death and Disease (2026)17:218; [https://doi.org/10.1038/s41419-026-08467-w](https://doi.org/10.1038/s41419-026-08467-w) |  |\n|  |  |  |\n\nINTRODUCTION  \nAccording to the latest data in 2022, there were 389,846 new cases of lip and oral cavity cancer, with oral squamous cell carcinoma (OSCC) accounting for more than 90% of all oral malignancies, posing a signiﬁcant burden on global health [1–4] . The progression and aggressiveness of OSCC are tightly linked to cancer stem cells (CSCs) [5] . Ferroptosis is a regulated form of irondependent cell death characterized by the accumulation of lipid peroxides due to oxidative stress [6] . Emerging evidence reveals a mechanistic convergence between cancer stemness regulatory networks and ferroptosis pathways [7, 8] . Mapping their interconnectivity may identify novel targets to disrupt CSCs-fueled tumor evolution and treatment failure.  \nKIF20A (Kinesin Family Member 20A) is a motor protein that plays a critical role in mitosis and intracellular transport [9–11] . Research has been increasingly recognized for its important roles in tumor pathology. It is reported to be highly expressed in  \nmultiple cancers, including pancreatic [12, 13], breast [14], lung [15], ovarian [16], and hepatocellular carcinoma [17], and correlated with poor prognosis, tumor progression, metastasis, and immune evasion [18, 19] . Moreover, KIF20A is overexpressed in glioma stem cells and connected to cancer stemness [20] . KIF20A stabilizes cancer stemness drivers like MYC through competitively inhibiting FBXW7-mediated degradation [21], while its depletion sensitizes lung adenocarcinoma cells to gemcitabine and ferroptosis inducer co-treatment via lipid peroxidation potentiation [1] . These ﬁndings support the hy","cbCaignBwnztQdk9","https://ap.wps.com/l/cbCaignBwnztQdk9","pdf",15448784,18,"English","# Introduction\n## Oral squamous cell carcinoma, cancer stem cells, and ferroptosis\n## KIF20A roles in tumors and stemness-related regulation\n## DHX9 as an mRNA stability and cancer progression factor","[{\"question\":\"What role does KIF20A play in OSCC progression and patient outcomes?\",\"answer\":\"KIF20A is significantly overexpressed in OSCC and strongly correlates with adverse clinical outcomes. It promotes cancer stem cell-like phenotypes and contributes to ferroptosis resistance.\"},{\"question\":\"How does KIF20A influence DHX9 stability?\",\"answer\":\"KIF20A alters DHX9 nucleocytoplasmic distribution and inhibits TRIM21-mediated K48-linked polyubiquitination at DHX9-K755. This prevents proteasomal degradation and enhances DHX9 protein stability.\"},{\"question\":\"How does DHX9 affect SOX2 and ferroptosis resistance?\",\"answer\":\"Elevated DHX9 increases SOX2 mRNA stability, leading to upregulation of SOX2. SOX2 then supports both cancer stem cell maintenance and resistance to ferroptosis.\"}]","KIF20A inhibits TRIM21-dependent ubiquitination of DHX9 to boost SOX2 stability - enhancing OSCC stemness and ferroptosis resistance | PDF",1790092631,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d67d8fcc26a0506000ab2fcff4049b72.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3fb74fee092794ab4f32dc38edc80a3c.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0dd7048189fb2a28fb8ea0e002b1748.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e711b2b5cee9fd51416daf31589a11a1.webp",980,1301]